Australian Centre for the Prevention of Cervical Cancer

The ACPCC has signed an MOU with Gavi, the Vaccine Alliance, to advance global efforts in cervical cancer prevention. This partnership builds on ACPCC's success in Australia, which has already significantly reduced cervical cancer rates. Now, the ACPCC will extend its impact, working with Gavi to improve access to HPV testing worldwide. Together, we are one step closer to a cervical cancer-free future. See the full story below. Australian Global Health Alliance, Australian Department of Foreign Affairs and Trade, Minderoo Foundation, INTERNATIONAL PAPILLOMAVIRUS SOCIETY - IPVS #CervicalCancer #HPVVaccine #GlobalHealth

🌟 #ECC2024 and the WHO Strategy🌍 #ECC2024's program is designed around the World Health Organization’s global cervical cancer elimination strategy: - Comprehensive vaccination for 90% of girls by age 15 - Effective screening for 70% of women by ages 35, and again by 45 - Treatment and care for 90% of women diagnosed with cervical precancer or cancer. Explore sessions led by regional experts dedicated to achieving these targets. 🎟️ Registration: - In-person: $1680 - Virtual: $420 Details and registration at https://lnkd.in/gedS4rAr. Don't miss ECC2024! #CervicalCancerElimination, The Australian National University, Kirby Institute, UNSW Sydney, University of Melbourne, The Daffodil Centre, BD.

A beautiful explainer on #HPVvaccine and #CervicalCancerElimination. Congrats to the Our World in Data team - it is wonderful to have this synthesis of so much research, vaccine development, epidemiology, and modeling in one place. Building on these developments, we are seeing tremendous progress. For example, the post has a map with 2021 data for # of countries with HPV vaccine programmes. But WHO shows that 28 countries have introduced the HPV vaccine since then! And more to come...

Cervical cancer survivors are such powerful champions for vaccination - having lived through this horrible disease, they are adamant that girls should be protected. This fabulous story from Mongolia highlights a survivor who had to give up her whole life to seek treatment, yet is still advocating for the upcoming vaccine launch. So inspired by Ainagul Samenbek's story! And looking forward to HPV introduction number 146!

The Australian HPV Reference Laboratory at the ACPCC is very proud to be the first Australian home of a Genius AI system - another great advancement in cervical screening! Public Pathology Australia, Pathology Technology Australia, The Royal College of Pathologists of Australasia (RCPA)

What an absolute honour to be part of an extremely productive multi-stakeholder 'Sarawak Cervical Cancer Elimination Programme' (SCCEP) workshop! It was exciting and encouraging to witness the alignment between all the different entities represented at this first workshop, particularly on the need to address the myths and misconceptions surrounding HPV, the importance of linkage to care and finally on the need of a live screening registry. There was an acknowledgement that we needed to prepare the 'third pillar'(follow-up)with before scaling HPV testing, adopting different models of 'screening and follow-up' in Sarawak and the importance of community engagement. A representative from the Sarawak Ministry of Education provided some statistics on girls who attended primary and secondary education, supporting the move towards vaccinating girls in primary school instead. Personally, as part of the team from ROSE Foundation, I am humbled to be included in this initiative. I look forward to exciting times ahead as I witnessed political commitment being converted to actionable small steps towards a 'cervical cancer free Sarawak' ROSE FOUNDATION Sarawak Infectious Disease Centre (SIDC) National Cancer Society Malaysia

We were truly honoured last week to welcome Karen Nakawala, a courageous cervical cancer survivor, WHO advocate, and founder of the Zambian NGO “The Teal Sisters.” Karen's impactful work in Zambia focuses on promoting early cervical cancer screening and breaking down taboos surrounding the topic. Through her inspiring radio broadcasts and thriving Facebook group with over 134,000 members, she is making a significant difference in raising awareness.

We’re thrilled to have 15 DFAT funded fellows here at University of Sydney to work with us on the elimination of cervical cancer in the Indopacific. Thanks to Dr Lucas de Toca PSM Robyn Ward Family Planning Australia Kirby Institute, UNSW Sydney for making this possible!

"Through delivering research, investing in the latest treatments and nurturing partnerships we can work towards a future free from cervical cancer". Mark Middleton OAM, CEO of the Icon Group joins an array of experts at ECC2024. Mark will speak on the third day of the conference, on the topic of developing radiotherapy capacity for cervical cancer treatment. Visit https://lnkd.in/gedS4rAr for details and registration.  The Daffodil Centre, Kirby Institute, UNSW Sydney, The Australian National University, University of Melbourne, Mark Middleton OAM, Icon Group

A unique opportunity to hear from the new CEO of Gavi, the Vaccine Alliance on 7th November in Canberra